GH Research PLC
NASDAQ:GHRS
8.61 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0.078 | 0.08 | 0.078 | 0.08 | 0.08 | 0.077 | 0.013 | 0.012 | 0 | 0.011 | 0.009 | 0.006 | 0.003 | 0.001 | 0 | 0 | 0 | 0 |
Gross Profit
| -0.078 | 0 | -0.078 | -0.08 | -0.08 | -0.077 | -0.013 | -0.012 | 0 | -0.011 | -0.009 | -0.006 | -0.003 | -0.001 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 9.75 | 8.652 | 8.251 | 7.088 | 7.176 | 7.306 | 6.91 | 4.62 | 4.24 | 4.714 | 3.351 | 2.556 | 1.954 | 0.692 | 0.233 | 0.055 | 0.039 | 0.011 |
General & Administrative Expenses
| 3.391 | 2.796 | 2.837 | 2.559 | 2.679 | 3.046 | 2.274 | 2.001 | 2.51 | 3.292 | 3.27 | 2.11 | 0.719 | 0.448 | 0.092 | 0.005 | 0.003 | 0.008 |
Selling & Marketing Expenses
| 0.003 | -0.05 | 0.071 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 3.394 | 2.746 | 2.908 | 2.559 | 2.679 | 3.046 | 2.274 | 2.001 | 2.51 | 3.292 | 3.27 | 2.11 | 0.719 | 0.448 | 0.092 | 0.005 | 0.003 | 0.008 |
Other Expenses
| -0.003 | 0 | 0 | 0 | 0 | 0.266 | -0.012 | 0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 13.144 | 11.398 | 11.159 | 9.736 | 9.708 | 10.618 | 9.172 | 6.626 | 6.75 | 8.006 | 6.621 | 4.666 | 2.673 | 1.14 | 0.325 | 0.06 | 0.042 | 0.019 |
Operating Income
| -13.222 | -11.478 | -11.159 | -9.719 | -9.925 | -10.419 | -9.172 | -6.626 | -6.75 | -8.006 | -6.621 | -4.666 | -2.673 | -1.14 | -0.325 | -0.06 | -0.042 | -0.019 |
Operating Income Ratio
| 0 | -143.475 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 2.843 | 3.812 | -0.113 | 3.09 | 1.125 | -0.518 | -7.414 | 6.185 | 7.084 | 2.243 | 2.53 | 2.832 | 0.554 | -0.009 | 0 | 0 | 0 | 0 |
Income Before Tax
| -10.379 | -7.666 | -11.272 | -5.649 | -7.729 | -10.937 | -16.586 | -0.441 | 0.334 | -5.763 | -4.091 | -1.837 | -2.125 | -1.149 | -0.325 | -0.06 | -0.042 | -0.019 |
Income Before Tax Ratio
| 0 | -95.825 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| -0 | -0 | 2.753 | 0.016 | 0.179 | 1.172 | 0.225 | -6.185 | -7.084 | -2.243 | -0 | 0.003 | 0.006 | 0.009 | 0 | -0.06 | -0.042 | -0.019 |
Net Income
| -10.379 | -7.666 | -11.272 | -5.649 | -7.729 | -12.109 | -16.811 | 5.744 | 7.418 | -3.52 | -4.091 | -1.837 | -2.125 | -1.149 | -0.325 | -0.06 | -0.042 | -0.019 |
Net Income Ratio
| 0 | -95.825 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.2 | -0.15 | -0.22 | -0.11 | -0.15 | -0.23 | -0.32 | 0.11 | 0.14 | -0.068 | -0.079 | -0.035 | -0.053 | -0.024 | -0.011 | -0.002 | -0.001 | -0.001 |
EPS Diluted
| -0.2 | -0.15 | -0.22 | -0.11 | -0.15 | -0.23 | -0.32 | 0.11 | 0.14 | -0.068 | -0.079 | -0.035 | -0.053 | -0.024 | -0.011 | -0.002 | -0.001 | -0.001 |
EBITDA
| -13.144 | -11.398 | -8.328 | -8.643 | -8.595 | -9.517 | -16.348 | -6.614 | -6.739 | -10.238 | -6.612 | -4.66 | -2.67 | -1.13 | -0.324 | -0.06 | -0.042 | -0.019 |
EBITDA Ratio
| 0 | -142.475 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |